Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2026-04-02 Board/Management Inform…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Updates
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the receipt of Central Government approval for the appointment of the Managing Director of the company. It references prior intimations about the appointment and encloses the approval letter. There is no financial data, report, or presentation included. The content pertains to management appointment approval, which fits the category of Board/Management Information (MANG). The document length is short and it is an announcement rather than a detailed report or filing. Therefore, the appropriate classification is MANG with high confidence.
2026-04-02 English
Please refer the attachment
Notice of Dividend Amount Classification · 100% confidence The document is a communication from Sanofi India Limited regarding the Tax Deduction at Source (TDS) on the Final Dividend for the financial year ended December 31, 2025. It details the dividend amount recommended by the Board, the tax deduction rules applicable to resident and non-resident shareholders, the process for submitting tax-related documents, and important dates related to dividend eligibility and tax declarations. The document does not contain financial statements or results but focuses on dividend payment and tax withholding information. It is an announcement related to dividend payment and tax deduction procedures rather than a report or financial statement. Therefore, it fits best under the category of Notice of Dividend Amount (DIV).
2026-04-02 English
Please refer the attachment
Report Publication Announcement Classification · 95% confidence The document is a letter dated 2nd April 2026 from Sanofi India Limited addressed to stock exchanges and shareholders. It informs recipients about the dispatch of letters containing weblink and QR code to access the Notice of the 70th Annual General Meeting (AGM) and the Integrated Annual Report for the financial year ended 31 December 2025. The letter explicitly states that the actual Annual Report and AGM Notice are available online and provides instructions for accessing them. The document does not contain the full Annual Report or AGM materials itself but is an announcement about the availability and access to these reports. The document length is 6777 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA) rather than the Annual Report (10-K) or AGM Information (AGM-R).
2026-04-02 English
Please refer the attachment
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the receipt of Central Government approval for the appointment of the Managing Director of the company. It references prior intimations about the appointment and encloses the approval letter. The content focuses on management appointment approval rather than financial results, reports, or other filings. The document length is short (1877 characters) and is a notification of a management change. Therefore, it fits the category of Board/Management Information (MANG).
2026-04-02 English
Updates
Environmental & Social Information Classification · 95% confidence The document is titled 'Business Responsibility and Sustainability Report (BRSR)' and is addressed pursuant to SEBI regulations, specifically Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It covers the financial year ended 31st December 2025 and forms part of the Integrated Annual Report for that year. The content includes detailed disclosures on environmental, social, governance, and sustainability matters, employee data, CSR details, grievance redressal mechanisms, and material responsible business conduct issues. The document is comprehensive and contains substantive non-financial data related to ESG factors. It is not an announcement of a report publication but the report itself, given the length (15,000 characters) and detailed content. Therefore, it fits the category of Environmental & Social Information (ESG) reports.
2026-04-02 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is a Notice of the 70th Annual General Meeting (AGM) of Sanofi India Limited scheduled for April 29, 2026. It includes details about the meeting agenda such as adoption of annual audited financial statements, dividend declarations, re-appointments and appointments of directors, approval of related party transactions, and other resolutions to be considered at the AGM. The document is clearly a formal notice sent to shareholders and stock exchanges pursuant to regulatory requirements. It is not the actual Annual Report or financial statements but the official meeting notice containing the agenda and resolutions to be voted on. Therefore, this document fits the category of AGM Information (AGM-R). The document length is substantial (15,000 characters), consistent with a detailed AGM notice including multiple resolutions and explanatory statements.
2026-04-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.